Gender Dysphoria, Adult

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Kerecis
KerecisIceland - Isafjordur
1 program
Tubularized augmented peritoneal cap vaginoplastyN/A1 trial
Active Trials
NCT07286123RecruitingEst. Jun 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
KerecisTubularized augmented peritoneal cap vaginoplasty

Clinical Trials (1)

NCT07286123KerecisTubularized augmented peritoneal cap vaginoplasty

Gender Affirming Vaginoplasty With Tubularized Augmented Peritoneal Cap (TAPCap) Utilizing Fish Skin Xenograft (Kerecis™)

Start: Jul 2025Est. completion: Jun 2027
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space